{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:20:17Z","timestamp":1787062817403,"version":"build-2736575974"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T00:00:00Z","timestamp":1757116800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis Musculoskeletal and Skin Diseases","doi-asserted-by":"crossref","award":["R01AR084202"],"award-info":[{"award-number":["R01AR084202"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis Musculoskeletal and Skin Diseases","doi-asserted-by":"crossref","award":["P30AR072581"],"award-info":[{"award-number":["P30AR072581"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006108","name":"NCATS","doi-asserted-by":"publisher","award":["UM1TR004402"],"award-info":[{"award-number":["UM1TR004402"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Autosomal dominant osteopetrosis (ADO) is a rare osteosclerotic disorder usually caused by missense variants in the CLCN7 gene, which results in impaired osteoclastic bone resorption. Penetrance is incomplete, and disease severity varies widely, even among relatives within the same family. Although ADO can cause visual loss, osteonecrosis, osteomyelitis, and bone marrow failure, the most common complication of ADO is fracture. We are conducting a natural history study to characterize disease progression and determinants of disease severity. We hypothesized that baseline BMD and bone turnover markers would correlate with self-reported fracture history. We report cross-sectional analysis of baseline data from the natural history study in 54 individuals (42 adults, 12 children). In adults, Z-scores for both volumetric (r\u00a0=\u20090.87, p\u00a0&amp;lt;\u2009.001) and areal BMD (aBMD) of the LS, and Z-scores for FN, and TH aBMD (r\u00a0=\u20090.77 to 0.78; p\u00a0&amp;lt;\u2009.001) were correlated with lifetime fracture number. Tartrate resistant acid phosphatase, a marker of osteoclast number, correlated positively with fracture (r\u00a0=\u20090.52, p\u00a0=\u2009.004) consistent with an adaptive response of higher numbers of osteoclasts among more severely affected individuals. However, fracture number correlated inversely with the bone resorption markers serum C-telopeptide (r\u00a0=\u2009\u22120.60, p\u00a0&amp;lt;\u2009.001) and urine N-telopeptide\/creatinine ratio (r\u00a0=\u2009\u22120.35, p\u00a0=\u2009.047), suggesting that ADO subjects who have the most reduced osteoclast activity have a greater tendency to fracture. Correlation coefficients between fractures, BMD, and bone turnover markers were similar when limited to the 37 adults with disease-causing CLCN7 variants. There were no statistically significant differences between subjects with the most common CLCN7 variant (G215R), the most common variant in our cohort, compared to other CLCN7 variants with respect to fracture, bone density measures, or biochemical markers of bone turnover. These data demonstrate that bone density and biochemical bone turnover markers are indicators of ADO severity as defined by fracture number.<\/jats:p>","DOI":"10.1093\/jbmr\/zjaf123","type":"journal-article","created":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T09:33:11Z","timestamp":1757151191000},"page":"150-157","source":"Crossref","is-referenced-by-count":1,"title":["Fractures are highly correlated with bone density and inversely correlated with bone turnover markers in autosomal dominant osteopetrosis"],"prefix":"10.1093","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0940-1911","authenticated-orcid":false,"given":"Michael J","family":"Econs","sequence":"first","affiliation":[{"name":"Department of Medicine, Indiana University School of Medicine , Indianapolis, IN 46202,","place":["United States"]},{"name":"Department of Medical and Molecular Genetics, Indiana University School of Medicine , Indianapolis, IN 46202,","place":["United States"]},{"name":"Indiana Center for Musculoskeletal Health, Indiana University School of Medicine , Indianapolis, IN 46202,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6415-4936","authenticated-orcid":false,"given":"Stuart J","family":"Warden","sequence":"additional","affiliation":[{"name":"Indiana Center for Musculoskeletal Health, Indiana University School of Medicine , Indianapolis, IN 46202,","place":["United States"]},{"name":"Department of Physical Therapy, School of Health and Human Sciences, Indiana University Indianapolis , Indianapolis, IN 46202,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8312-6608","authenticated-orcid":false,"given":"Ziyue","family":"Liu","sequence":"additional","affiliation":[{"name":"Indiana Center for Musculoskeletal Health, Indiana University School of Medicine , Indianapolis, IN 46202,","place":["United States"]},{"name":"Department of Biostatistics and Data Science, Indiana University School of Public Health , Indianapolis, IN 46202,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4391-7508","authenticated-orcid":false,"given":"Paul J","family":"Niziolek","sequence":"additional","affiliation":[{"name":"Department of Radiology, Indiana University School of Medicine , Indianapolis, IN 46202,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Parks-Schenck","sequence":"additional","affiliation":[{"name":"Department of Medicine, Indiana University School of Medicine , Indianapolis, IN 46202,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3358-1712","authenticated-orcid":false,"given":"Netsanet","family":"Gebregziabher","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Data Science, Indiana University School of Public Health , Indianapolis, IN 46202,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita L","family":"Gerard-O'Riley","sequence":"additional","affiliation":[{"name":"Department of Medicine, Indiana University School of Medicine , Indianapolis, IN 46202,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Hart","sequence":"additional","affiliation":[{"name":"Department of Medicine, Indiana University School of Medicine , Indianapolis, IN 46202,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2881-6138","authenticated-orcid":false,"given":"Lynda E","family":"Polgreen","sequence":"additional","affiliation":[{"name":"The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center , Torrance, CA 90502,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7284-3467","authenticated-orcid":false,"given":"Erik A","family":"Imel","sequence":"additional","affiliation":[{"name":"Department of Medicine, Indiana University School of Medicine , Indianapolis, IN 46202,","place":["United States"]},{"name":"Indiana Center for Musculoskeletal Health, Indiana University School of Medicine , Indianapolis, IN 46202,","place":["United States"]},{"name":"Department of Pediatrics, Indiana University School of Medicine , Indianapolis, IN 46202,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,9,6]]},"reference":[{"issue":"1","key":"2026020308315040700_ref1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/8756-3282(88)90021-X","article-title":"Radiological, biochemical and hereditary evidence of two types of autosomal dominant osteopetrosis","volume":"9","author":"Bollerslev","year":"1988","journal-title":"Bone"},{"issue":"2","key":"2026020308315040700_ref2","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/00005792-196803000-00004","article-title":"Osteopetrosis. A clinical, genetic, metabolic, and morphologic study of the dominantly inherited, benign form","volume":"47","author":"Johnston","year":"1968","journal-title":"Medicine (Baltimore)"},{"issue":"25","key":"2026020308315040700_ref3","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1093\/hmg\/10.25.2861","article-title":"Albers-Schonberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene","volume":"10","author":"Cleiren","year":"2001","journal-title":"Hum Mol Genet"},{"issue":"8","key":"2026020308315040700_ref4","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1359\/jbmr.2003.18.8.1513","article-title":"Chloride channel 7 (ClCN7) gene mutations and autosomal dominant osteopetrosis, type II","volume":"18","author":"Waguespack","year":"2003","journal-title":"J Bone Miner Res"},{"issue":"7","key":"2026020308315040700_ref5","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1210\/clinem\/dgae040","article-title":"Autosomal dominant osteopetrosis (ADO) caused by a missense variant in the TCIRG1 gene","volume":"109","author":"Jodeh","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026020308315040700_ref6","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1210\/jc.2006-1986","article-title":"Autosomal dominant osteopetrosis: clinical severity and natural history of 94 subjects with a chloride channel 7 gene mutation","volume":"92","author":"Waguespack","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026020308315040700_ref7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S8756-3282(99)00244-6","article-title":"Type II autosomal dominant osteopetrosis (Albers-Schonberg disease): clinical and radiological manifestations in 42 patients","volume":"26","author":"Benichou","year":"2000","journal-title":"Bone"},{"key":"2026020308315040700_ref8","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.bone.2018.02.031","article-title":"RNA interference therapy for autosomal dominant osteopetrosis type 2. Towards the preclinical development","volume":"110","author":"Maurizi","year":"2018","journal-title":"Bone"},{"key":"2026020308315040700_ref9","doi-asserted-by":"publisher","first-page":"e248","DOI":"10.1038\/mtna.2015.21","article-title":"Effective small interfering RNA therapy to treat CLCN7-dependent autosomal dominant osteopetrosis type 2","volume":"4","author":"Capulli","year":"2015","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"2026020308315040700_ref10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00223-024-01222-3","article-title":"Effect of allele-specific Clcn7(G213R) siRNA delivered via a novel nanocarrier on bone phenotypes in ADO2 mice on 129S background","volume":"115","author":"Saffie-Siebert","year":"2024","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"2026020308315040700_ref11","doi-asserted-by":"publisher","first-page":"e607","DOI":"10.1210\/clinem\/dgae285","article-title":"Patient-reported outcomes in autosomal dominant Osteopetrosis: findings from the osteopetrosis registry study","volume":"110","author":"Polgreen","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2026020308315040700_ref12","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00256-020-03625-3","article-title":"Radiographic imaging, densitometry and disease severity in autosomal dominant osteopetrosis type 2","volume":"50","author":"Ladd","year":"2021","journal-title":"Skeletal Radiol"},{"issue":"1","key":"2026020308315040700_ref13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/8756-3282(85)90399-0","article-title":"Quantitative computed tomography for prediction of vertebral fracture risk","volume":"6","author":"Cann","year":"1985","journal-title":"Bone"},{"issue":"10","key":"2026020308315040700_ref14","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1210\/jc.2011-1111","article-title":"Revised reference curves for bone mineral content and areal bone mineral density according to age and sex for black and non-black children: results of the bone mineral density in childhood study","volume":"96","author":"Zemel","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2026020308315040700_ref15","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nrendo.2013.137","article-title":"Osteopetrosis: genetics, treatment and new insights into osteoclast function","volume":"9","author":"Sobacchi","year":"2013","journal-title":"Nat Rev Endocrinol"},{"issue":"7","key":"2026020308315040700_ref16","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1359\/jbmr.060409","article-title":"Disease status in autosomal dominant osteopetrosis type 2 is determined by osteoclastic properties","volume":"21","author":"Chu","year":"2006","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2026020308315040700_ref17","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/jmg.2005.036673","article-title":"Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment","volume":"43","author":"Del Fattore","year":"2006","journal-title":"J Med Genet"},{"issue":"1","key":"2026020308315040700_ref18","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00223-017-0332-x","article-title":"Clinical significance of DXA and HR-pQCT in autosomal dominant osteopetrosis (ADO II)","volume":"102","author":"Butscheidt","year":"2018","journal-title":"Calcif Tissue Int"},{"issue":"5","key":"2026020308315040700_ref19","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/oxfordjournals.aje.a116315","article-title":"The accuracy of self-report of fractures in elderly women: evidence from a prospective study","volume":"135","author":"Nevitt","year":"1992","journal-title":"Am J Epidemiol"},{"issue":"3","key":"2026020308315040700_ref20","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s001980050288","article-title":"Validity of self-report of fractures: results from a prospective study in men and women across Europe. EPOS Study Group. European Prospective Osteoporosis Study Group","volume":"11","author":"Ismail","year":"2000","journal-title":"Osteoporos Int"},{"issue":"3","key":"2026020308315040700_ref21","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/01.GME.0000094210.15096.FD","article-title":"Validity of self-report for fractures among a multiethnic cohort of postmenopausal women: results from the Women's Health Initiative observational study and clinical trials","volume":"11","author":"Chen","year":"2004","journal-title":"Menopause"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jbmr\/advance-article-pdf\/doi\/10.1093\/jbmr\/zjaf123\/64216760\/zjaf123.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/41\/2\/150\/64216760\/zjaf123.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/41\/2\/150\/64216760\/zjaf123.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T13:32:01Z","timestamp":1770125521000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/41\/2\/150\/8248687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,6]]},"references-count":21,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,9,6]]},"published-print":{"date-parts":[[2026,2,3]]}},"URL":"https:\/\/doi.org\/10.1093\/jbmr\/zjaf123","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2025,9,6]]}}}